Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

Last updated 8/26/2026, 9:59:13 PM

Cite this record

African DSI DataBank. Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.. AFDSI-PUB-375. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-375 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42142877/.Copy citation

@misc{AFDSIPUB375,
  title        = {Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-375}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-375; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42142877/}
}

AFDSI-PUB-375 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.